Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 4, 2009, Pages 637-642

  Kopp, H G ^a   Yildirim, S ^a   Weisel, K C ^a   Kanz, L ^a   Vogel, W ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Contamination; High dose chemotherapy; Multiple myeloma; Plasma cells

Indexed keywords

ALPHA INTERFERON; BENDAMUSTINE; BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; LENALIDOMIDE; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THALIDOMIDE;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RELAPSE; CAUSE OF DEATH; CONTAMINATION; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; OVERALL SURVIVAL; PLASMA CELL; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD38; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IFOSFAMIDE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; SURVIVAL ANALYSIS; SYNDECAN-1; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 61449110002     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-008-0499-7     Document Type: Article

References (21)

1. M Attal JL Harousseau AM Stoppa JJ Sotto JG Fuzibet JF Rossi P Casassus H Maisonneuve T Facon N Ifrah C Payen R Bataille 1996 A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome N Engl J Med 335 91 97
2. M Attal JL Harousseau T Facon F Guilhot C Doyen JG Fuzibet M Monconduit C Hulin D Caillot R Bouabdallah L Voillat JJ Sotto B Grosbois R Bataille 2003 Single versus double autologous stem-cell transplantation for multiple myeloma N Engl J Med 349 2495 2502
3. AM Barbui M Galli G Dotti N Belli G Borleri G Gritti P Bellavita P Viero B Comotti T Barbui A Rambaldi 2002 Negative selection of peripheral blood stem cells to support a tandem autologous transplantation programme in multiple myeloma Br J Haematol 116 202 210
4. Barlogie B, van Rhee F, Shaughnessy JD Jr, Anaissie E, Crowley J (2008) Making progress in treating multiple myeloma with total therapies: issue of complete remission and more. Leukemia 22(8):1633-1636
5. JH Bourhis Y Bouko S Koscielny M Bakkus H Greinix G Derigs G Salles W Feremans J Apperley D Samson B Bjorkstrand D Niederwieser G Gahrton JL Pico H Goldschmidt 2007 Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study Haematologica 92 1083 1090
6. D Dingli GS Nowakowski A Dispenzieri MQ Lacy SR Hayman SV Rajkumar PR Greipp MR Litzow DA Gastineau TE Witzig MA Gertz 2006 Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system Blood 107 3384 3388
7. H Einsele M Bamberg W Budach H Schmidberger CF Hess B Wormann C Meisner C Straka H Hebart L Trumper N Kroger AR Zander S Hegewisch-Becker DK Hossfeld H Schmidt P Muller G Schlimok B Hertenstein D Peest B Metzner N Frickhofen L Kanz WI Bensinger 2003 A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma Bone Marrow Transplant 32 593 599
8. G Gahrton 2005 Progress in hematopoietic stem cell transplantation in multiple myeloma Curr Opin Hematol 12 463 470
9. Y Gazitt CC Reading R Hoffman A Wickrema DH Vesole S Jagannath J Condino B Lee B Barlogie G Tricot 1995 Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells Blood 86 381 389
10. MA Gertz TE Witzig AA Pineda PR Greipp RA Kyle MR Litzow 1997 Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation Bone Marrow Transplant 19 337 342
11. MA Gertz MQ Lacy A Dispenzieri SR Hayman SK Kumar 2006 High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma Expert Rev Anticancer Ther 6 343 360
12. RM Lemoli M Cavo A Fortuna 1996 Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma J Hematother 5 339 349
13. RM Lemoli G Martinelli A Olivieri MR Motta S Rizzi C Terragna G Leopardi M Benni S Ronconi I Cantori D Rondelli S Mangianti P Leoni M Montanari M Cavo S Tura 1999 Selection and transplantation of autologous CD34+ B-lineage negative cells in advanced-phase multiple myeloma patients: a pilot study Br J Haematol 107 419 428
14. RM Lemoli G Martinelli E Zamagni MR Motta S Rizzi C Terragna R Rondelli S Ronconi A Curti F Bonifazi S Tura M Cavo 2000 Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy Blood 95 2234 2239
15. H Ludwig K Strasser-Weippl M Schreder N Zojer 2007 Advances in the treatment of hematological malignancies: current treatment approaches in multiple myeloma Ann Oncol 18 ix64 ix70
16. M Michallet T Philip I Philip H Godinot C Sebban G Salles A Thiebaut P Biron F Lopez P Mazars N Roubi T Leemhuis E Hanania C Reading G Fine K Atkinson C Juttner B Coiffier D Fiere E Archimbaud 2000 Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution Exp Hematol 28 858 870
17. GS Nowakowski TE Witzig D Dingli MJ Tracz MA Gertz MQ Lacy JA Lust A Dispenzieri PR Greipp RA Kyle SV Rajkumar 2005 Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma Blood 106 2276 2279
18. G Schiller R Vescio C Freytes G Spitzer F Sahebi M Lee CH Wu J Cao JC Lee CH Hong 1995 Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma Blood 86 390 397
19. AK Stewart R Vescio G Schiller O Ballester S Noga H Rugo C Freytes E Stadtmauer S Tarantolo F Sahebi P Stiff J Meharchard R Schlossman R Brown H Tully M Benyunes C Jacobs R Berenson M White J DiPersio KC Anderson J Berenson 2001 Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial J Clin Oncol 19 3771 3779
20. CM Thirukkumaran JA Russell DA Stewart DG Morris 2007 Viral purging of haematological autografts: should we sneeze on the graft? Bone Marrow Transplant 40 1 12
21. W Vogel HG Kopp L Kanz H Einsele 2005 Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation J Cancer Res Clin Oncol 131 214 218